ArticleCureus2025
Progressive Motor and Cognitive Dysfunction in Fahr's Disease: A Clinical Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early-onset Fahr's disease with acute psychosis in a 20-year-old male with SLC20A2 mutation: A case report and literature review.Radiology case reports · 2026Article
- [A case report of severe hypocalcemia secondary to Fahr's syndrome].Anales del sistema sanitario de Navarra · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fahr's disease, or idiopathic basal ganglia calcification, is a rare neurodegenerative disorder characterized by the deposition of calcium salts in the basal ganglia, leading to a spectrum of neurological, cognitive, and psychiatric symptoms. This case report presents a 55-year-old female with a one-year history of progressive motor dysfunction, including tremors, dysarthria, and ataxia, along with cognitive decline and personality changes. Imaging studies revealed bilateral basal ganglia calcifications on both CT and MRI, confirming the diagnosis of Fahr's disease. The patient was started on symptomatic treatment with levodopa-carbidopa for motor symptoms and antidepressants for psychiatric disturbances. Despite some improvement in motor function, her cognitive decline continued to progress. The case emphasizes the importance of neuroimaging in diagnosing Fahr's disease and highlights the challenges of managing this rare disorder, particularly in its sporadic form. Treatment remains symptomatic, and a multidisciplinary approach is essential to address the diverse needs of patients. This case contributes to the understanding of Fahr's disease and underscores the need for further research into its pathophysiology and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.